KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $659.0 million.

  • Gilead Sciences' Deferred Taxes rose 21440.97% to $659.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$97.0 million, marking a year-over-year increase of 9471.39%. This contributed to the annual value of -$1.8 billion for FY2024, which is 9168.4% down from last year.
  • Per Gilead Sciences' latest filing, its Deferred Taxes stood at $659.0 million for Q3 2025, which was up 21440.97% from -$178.0 million recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Deferred Taxes ranged from a high of $659.0 million in Q3 2025 and a low of -$723.0 million during Q1 2024
  • Its 5-year average for Deferred Taxes is -$220.6 million, with a median of -$270.0 million in 2022.
  • As far as peak fluctuations go, Gilead Sciences' Deferred Taxes surged by 29834.71% in 2021, and later crashed by 101690.14% in 2022.
  • Quarter analysis of 5 years shows Gilead Sciences' Deferred Taxes stood at -$359.0 million in 2021, then rose by 5.85% to -$338.0 million in 2022, then fell by 9.47% to -$370.0 million in 2023, then decreased by 2.43% to -$379.0 million in 2024, then skyrocketed by 273.88% to $659.0 million in 2025.
  • Its last three reported values are $659.0 million in Q3 2025, -$178.0 million for Q2 2025, and -$199.0 million during Q1 2025.